Most people lose nothing in the first month.
The titration schedule is the reason. You start at 0.25 mg, a dose so low that it's barely above placebo for weight loss. The first four weeks are about your gut adapting, not about the scale moving. The real loss starts at month two, accelerates through months three and six, and tops out somewhere between week 60 and week 68 in clinical trials. Knowing that timeline is the difference between staying patient through the boring part and quitting before the drug actually starts working.
If you're starting semaglutide and want a predictable monthly cost during the slow phase, Yucca Health offers compounded semaglutide at $146 to $258 per month under physician oversight. The pricing matters because the titration phase is when most people stop, often because they were paying $1,300 a month for a drug that hadn't done much yet. The week-by-week guide below is built around what actually happens in the body across the full 68-week protocol.
🔑 Key Takeaways
- Semaglutide works on a fixed titration schedule: 0.25 mg for the first 4 weeks, then doubling roughly every month until you reach 2.4 mg around week 17
- Appetite suppression usually kicks in by weeks 1 to 2, but actual scale movement is minimal during the first 4 weeks because the dose is too low
- The first real weight loss shows up in weeks 5 to 12 (typically 3 to 8 lbs), peaks between months 3 and 6, and continues at a slower rate through week 68
- Average STEP 1 weight loss was 14.9% at 68 weeks. About half of participants lost more than 15%, and roughly 1 in 3 lost more than 20%
- Results vary by starting weight, dose tolerance, food choices, protein intake, and resistance training, but the basic timeline is consistent
- If you're not losing by week 12 at the 1.0 mg dose, that's the prompt to recheck your protocol, not a reason to give up
Semaglutide Results Timeline at a Glance
Here's the full month-by-month curve.
| Time on semaglutide | Typical dose | Avg weight loss (cumulative) | What you'll notice |
|---|---|---|---|
| Week 1-2 | 0.25 mg | 0-2 lbs | Appetite suppression starts, mild nausea, "food noise" quieter |
| Week 3-4 | 0.25 mg | 2-4 lbs | First small visible loss, smaller portions feel natural |
| Month 2 (weeks 5-8) | 0.5 mg | 4-9 lbs (~3%) | Loss accelerates, energy stabilizes after initial fatigue |
| Month 3 (weeks 9-12) | 1.0 mg | 8-15 lbs (~5-6%) | Clothing fits differently, first photo-visible changes |
| Month 4 (weeks 13-16) | 1.7 mg | 12-22 lbs (~7-9%) | Steady loss, fitness improves, blood pressure trending down |
| Month 5-6 (weeks 17-24) | 2.4 mg | 18-32 lbs (~10-13%) | Peak loss phase, biggest week-over-week changes |
| Month 7-9 (weeks 25-36) | 2.4 mg | 25-42 lbs (~13-16%) | Loss slows but continues, body composition shifts |
| Month 10-12 (weeks 37-52) | 2.4 mg | 30-50 lbs (~15-18%) | Approaching plateau, focus shifts to muscle and habits |
| Month 13-17 (weeks 53-68) | 2.4 mg | 32-55 lbs (~15-20%) | Maximum loss in STEP 1, transition to maintenance discussion |
The percentages above are from STEP 1 averages for a 200-lb starting weight, scaled to typical real-world results. The lbs numbers will be higher if you're heavier, lower if you're lighter.
How Fast Does Semaglutide Work?
Two things happen on two different timelines.
The appetite effect is fast. Most people notice it within 7 to 14 days of the first injection. Hunger between meals fades. The persistent mental chatter about food (often called "food noise") goes quiet. Portions that felt normal a week ago feel large now. This is the GLP-1 receptor activating in your hypothalamus and brainstem, and it happens on the first dose because the receptor responds immediately to the drug.
The weight-loss effect is slow, and that's the disconnect that confuses most people. You feel less hungry by week 2, but the scale barely moves for the first month. The reason is dose: at 0.25 mg weekly, you're below the therapeutic threshold for significant weight loss. That dose exists to let your gut adapt to slowed gastric emptying without sending you into severe nausea. The drug doesn't really start moving weight until you escalate to 0.5 mg in week 5, and the curve only steepens at 1.0 mg from week 9.
Why the first month feels disappointing
You're paying full price for what is essentially a slow on-ramp. The 0.25 mg starting dose is designed to be subtherapeutic, an adaptation phase rather than a treatment phase. People who quit during the first month usually do so because the cost-to-result ratio looks terrible. Most prescribers don't explain this clearly enough up front. Knowing the curve is built this way is the single biggest predictor of staying on long enough to see real results.
Week 1 to Week 2 Results: The Adaptation Phase
Dose: 0.25 mg weekly. Expected weight loss: 0 to 2 lbs.
The first two weeks are about your gut, not your scale. After the first injection, you might notice mild nausea within 24 to 72 hours, especially after meals that are larger than your stomach now wants to handle. Food noise quiets within the first 7 to 10 days for most people. You'll eat your usual portion and feel uncomfortably full halfway through.
What scale changes you do see are mostly water weight from reduced food intake. Don't read too much into them. The real signal in weeks 1 to 2 is appetite: if hunger between meals has dropped, the drug is working as intended. If you feel no appetite change by the end of week 2, mention it to your prescriber. A small number of people are GLP-1 non-responders, and it's worth knowing earlier rather than later.
Week 3 to Week 4 Results: First Visible Loss
Dose: 0.25 mg weekly. Expected weight loss: 2 to 4 lbs cumulative.
By the end of week 4, most people see 2 to 4 lbs gone. It's small, but it's the first time the scale agrees with what you've been feeling for two weeks. The "I'm not hungry" sensation is now stable across the day. You start automatically eating smaller portions without thinking about it. Side effects from the early nausea phase have usually faded.
This is when most people get their first dose increase to 0.5 mg, typically at the start of week 5. If your nausea was significant, your prescriber may keep you on 0.25 mg for another 4 weeks before escalating. Pushing the dose up before the gut is ready is the most common cause of dropping out of treatment, so the 4-week-per-step schedule exists for a reason.
Month 2 Results (Weeks 5 to 8): Loss Accelerates
Dose: 0.5 mg weekly. Expected weight loss: 4 to 9 lbs cumulative (about 3% of body weight).
The 0.5 mg dose is where things change. Appetite suppression deepens, and the drug now has enough receptor occupancy to produce meaningful weight loss. Most people lose 1 to 2 lbs per week during this stretch. Clothing fits differently, especially around the waist. Energy levels typically stabilize after the initial fatigue that some people experience during the first few weeks.
You may notice you can't drink as much water as you used to, that high-fat meals make you queasy, and that the smell of certain foods (often previous favorites like fried foods or sweets) is suddenly unappealing. These are all expected GLP-1 effects and signs that the drug is working at the level it's supposed to.
Month 3 Results (Weeks 9 to 12): The First Real Inflection
Dose: 1.0 mg weekly. Expected weight loss: 8 to 15 lbs cumulative (about 5 to 6% of body weight).
Month 3 is when results become visible to people around you. The cumulative loss is enough to change how your face looks, how shirts and dresses hang, and how the scale reads. This is also the dose at which most people hit their early plateau if their food choices haven't shifted. The drug suppresses appetite, but if you're still eating 800 calories of pizza and feeling full, you're going to lose less than if you're eating 800 calories of protein and vegetables.
Body composition starts shifting noticeably here. Without resistance training and adequate protein, 25 to 35% of the weight you've lost so far is lean mass. That's the most common semaglutide mistake. See the GLP-1 medications overview for the mechanism, but the practical fix is 1.2 to 1.6 grams of protein per kilogram of body weight per day plus resistance training 2 to 3 times per week.
Month 4 to Month 6: Peak Loss Phase
Doses: 1.7 mg (month 4), 2.4 mg (months 5-6). Expected weight loss: 18 to 32 lbs cumulative (about 10 to 13% of body weight by month 6).
This is the biggest weight-loss window in the entire protocol. Most people lose more in months 4 through 6 than they lost in the first three months combined. The 2.4 mg maintenance dose is the peak therapeutic effect, and your body composition is changing fast enough that you may need to update measurements every 4 weeks instead of every 8.
What people often miss in this phase is that the weekly loss rate starts at about 1.5 to 2 lbs and gradually drops to 1 lb by the end of month 6. That deceleration is normal. Your body has less mass to support, so you need fewer calories, so the deficit shrinks. Don't read the deceleration as the drug failing. It's metabolic adaptation, and it happens to everyone.
Month 7 to Month 12: Slower, Steadier Progress
Dose: 2.4 mg weekly. Expected weight loss: 30 to 50 lbs cumulative by month 12 (about 15 to 18% of body weight).
Loss continues but at a more modest pace. Months 7 through 12 add another 5 to 10 lbs on average, mostly because the body is now defending its new weight more aggressively. This is the phase where structured tracking starts to matter: macros, training intensity, sleep, and stress management all become more visible drivers of further progress.
For people who reach a comfortable weight before month 12, this is when the maintenance dose conversation usually starts. Some people taper to 1.0 mg, others stay on 2.4 mg through month 17. The decision is usually based on whether you've stabilized at a weight you're happy with or still have specific goals ahead.
Month 13 to Month 17: Maximum Loss in STEP 1
Dose: 2.4 mg weekly. Expected weight loss: 32 to 55 lbs cumulative (about 15 to 20% of body weight).
STEP 1 ran for 68 weeks, ending around month 17. By the end, the average participant had lost 14.9% of starting body weight, and roughly half had lost 15% or more. About 1 in 3 had lost 20% or more. Beyond month 17, weight loss largely plateaus on a stable dose. To continue losing past this point, either the dose stays at 2.4 mg and lifestyle changes intensify, or a different drug like tirzepatide gets considered.
Semaglutide Results by Starting Weight
Heavier people lose more in absolute pounds.
| Starting weight | ~15% (avg STEP 1) | ~20% (good responder) | ~10% (slower responder) |
|---|---|---|---|
| 180 lbs | 27 lbs lost | 36 lbs lost | 18 lbs lost |
| 220 lbs | 33 lbs lost | 44 lbs lost | 22 lbs lost |
| 250 lbs | 37 lbs lost | 50 lbs lost | 25 lbs lost |
| 280 lbs | 42 lbs lost | 56 lbs lost | 28 lbs lost |
| 320 lbs | 48 lbs lost | 64 lbs lost | 32 lbs lost |
About 1 in 7 people lose less than 5% of body weight on semaglutide. They're called clinical non-responders. If you're under 5% loss at week 20 on the full 2.4 mg dose, that's usually the threshold for switching to a different GLP-1 (typically tirzepatide) rather than continuing.
Signs Semaglutide Is Actually Working
The scale is not the only or even the best early indicator.
- Reduced food noise. The internal chatter about food, snacking impulses, and meal planning anxiety quiets, often within 10 days.
- Smaller portions feel natural. You stop mid-meal because you're full, not because you're trying to stop.
- Longer gaps between meals. You forget to eat for 4 to 6 hours at a time, where previously 2 to 3 hours was the limit.
- Cravings shift. Foods you used to want frequently (often sweet or fried) become less appealing or even unappealing.
- Alcohol tolerance changes. Many people report wanting less alcohol or feeling drunker faster on smaller amounts.
- Better blood sugar control. For people with T2D, A1c starts dropping by week 4 to 6 even before significant weight loss.
- Energy stabilizes. After an initial 1- to 2-week fatigue period, energy levels become more consistent across the day.
What If You're Not Losing Weight on Semaglutide?
It happens. Most of the time it's fixable.
The decision tree if the scale isn't moving
- Are you actually at the therapeutic dose? 0.25 mg and 0.5 mg are not weight-loss doses. Most loss happens at 1.0 mg and above.
- Has it been long enough? Below week 8, expecting major loss is unrealistic. Below week 16, expecting the maximum loss rate is unrealistic.
- What are you eating? Semaglutide reduces hunger, it does not reduce calories. If you eat 1,500 calories of high-fat foods because they're easier to keep down with nausea, you may stall.
- Are you getting enough protein? Below about 80g/day, muscle loss accelerates and water-weight fluctuations mask fat loss on the scale.
- Are you resistance training? Without it, much of what looks like weight loss is muscle loss, and the scale is misleading.
- Are you a non-responder? About 1 in 7 don't respond meaningfully even at full dose. The full plateau and non-responder guide covers this in detail.
Comparing Semaglutide Results to Other GLP-1 Drugs
Semaglutide is the second-best in the class right now.
| Drug | Trial | Duration | Avg weight loss |
|---|---|---|---|
| Semaglutide 2.4 mg (Wegovy) | STEP 1 | 68 weeks | ~15% |
| Semaglutide 2.4 mg high-dose (Wegovy HD) | STEP UP | 72 weeks | ~19% |
| Oral semaglutide 25 mg (Wegovy pill) | OASIS 4 | 71 weeks | ~14% |
| Tirzepatide 15 mg (Zepbound) | SURMOUNT-1 | 72 weeks | ~21% |
| Tirzepatide vs semaglutide head-to-head | SURMOUNT-5 | 72 weeks | 20.2% vs 13.7% |
| Retatrutide 12 mg (investigational) | Phase 2 | 48 weeks | ~24% |
Tirzepatide produces about 47% more weight loss than semaglutide in head-to-head data. Retatrutide is still in trials but Phase 2 data suggests roughly 24% loss, which would make it the most effective of the class once approved. For most people deciding right now, semaglutide is the most affordable and accessible option, with tirzepatide a step up for people who can pay for it.
Frequently Asked Questions
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Semaglutide is a prescription medication, and decisions about starting, adjusting, or continuing treatment should be made with a licensed healthcare provider who knows your full medical history. Individual results vary significantly based on starting weight, dose, food choices, exercise, and other factors.